Australia markets closed

Eton Pharmaceuticals, Inc. (ETON)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.6800+0.1800 (+5.14%)
At close: 04:00PM EDT
3.6800 0.00 (0.00%)
Pre-market: 08:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 93.76M
Enterprise value 77.78M
Trailing P/E N/A
Forward P/E 64.94
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.96
Price/book (mrq)6.06
Enterprise value/revenue 2.46
Enterprise value/EBITDA -267.27

Trading information

Stock price history

Beta (5Y monthly) 1.18
52-week change 33.37%
S&P500 52-week change 323.57%
52-week high 35.8100
52-week low 32.4200
50-day moving average 33.8260
200-day moving average 34.0403

Share statistics

Avg vol (3-month) 360.53k
Avg vol (10-day) 340.33k
Shares outstanding 525.69M
Implied shares outstanding 625.69M
Float 821.88M
% held by insiders 15.25%
% held by institutions 127.97%
Shares short (15 Apr 2024) 4148.06k
Short ratio (15 Apr 2024) 41.79
Short % of float (15 Apr 2024) 40.61%
Short % of shares outstanding (15 Apr 2024) 40.58%
Shares short (prior month 15 Mar 2024) 4242.91k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -2.96%
Operating margin (ttm)-27.25%

Management effectiveness

Return on assets (ttm)-2.62%
Return on equity (ttm)-6.56%

Income statement

Revenue (ttm)31.64M
Revenue per share (ttm)1.23
Quarterly revenue growth (yoy)-13.90%
Gross profit (ttm)N/A
EBITDA -358k
Net income avi to common (ttm)-936k
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)21.39M
Total cash per share (mrq)0.83
Total debt (mrq)5.46M
Total debt/equity (mrq)35.25%
Current ratio (mrq)1.65
Book value per share (mrq)0.60

Cash flow statement

Operating cash flow (ttm)6.82M
Levered free cash flow (ttm)5.6M